Third, our findings have indicated significantly decreased proportions of endometrial CD56+ NK cells, CD8+ T cells, Fopx3+ Treg cells, and T-bet+ Th1 cells in persistent CE patients after PRP treatment. The gene discussed is NCAM1; the disease is cholesteryl ester measurement.